ReviewFrontiers in aging neuroscience2021

Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Upasana Ganguly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.